Syncom Formulations is trading at ₹19.84, 5.64% up after rising from ₹18.78 on September 17, 2026.
- No clear company-specific catalyst was identified for September 18, 2026.
- Recent disclosures cover routine AGM notices, the FY2025-26 annual report, sustainability reporting, and a ₹0.10 dividend with a September 23 ex-date; none are explicitly linked to the increase.